RNTX Rein Therapeutics, Inc.
$0.80
Rein Therapeutics, Inc. (RNTX) Earnings News
Earnings press releases, previews and reviews for Rein Therapeutics, Inc. (RNTX), newest first.
Thursday
August 20, 2026
8:00 AM ET
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
Friday
August 14, 2026
6:44 AM ET
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Monday
May 18, 2026
8:00 AM ET
Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option
Thursday
April 30, 2026
8:00 PM ET
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock